4-Pyridone-3-carboxylic acid as a benzoic acid bioisostere: Design, synthesis, and evaluation of EP300/CBP histone acetyltransferase inhibitors-Reference-Cited by-同舟云学术

4-Pyridone-3-carboxylic acid as a benzoic acid bioisostere: Design, synthesis, and evaluation of EP300/CBP histone acetyltransferase inhibitors

Published:2021-11 Issue: Volume:51 Page:128358
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Kanada Ryutaro,Suzuki Takashi,Murata Takeshi,Miyazaki Masaki,Shimada Takashi,Kuroha Mutsumi,Minami Megumi,Higuchi Saito,Tominaga Yuichi,Naito Hiroyuki

Funder

National Cancer Research Institute

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference29 articles.

1. The complex language of chromatin regulation during transcription;Berger;Nature,2007

2. Gene activation by histone and factor acetyltransferases;Berger;Curr Opin Cell Biol.,1999

3. FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma;Mann;Oncologist,2007

4. Activity of the histone deacetylase inhibitor belinostat (PXD101) in preclinical models of prostate cancer;Qian;Int J Cancer,2008

5. Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor-dependent human lung cancer cells;Edwards;Mol Cancer Ther,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of an EP300 Inhibitor using Structure-based Virtual Screening andBioactivity Evaluation;Current Pharmaceutical Design;2024-07

2. An insight into therapeutic efficacy of heterocycles as histone‐modifying enzyme inhibitors that targets cancer epigenetic pathways;Chemical Biology & Drug Design;2022-09-16